Suppr超能文献

金属硫蛋白 1 同工型和波形蛋白是白血病细胞中 PU.1 的直接下游靶基因。

Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.

机构信息

Division of Molecular Hematology, Kitasato University Graduate School of Medical Sciences, 1-15-1 Kitasato, Minamiku, Sagamihara 252-0373, Japan.

出版信息

J Biol Chem. 2010 Apr 2;285(14):10300-9. doi: 10.1074/jbc.M109.095810. Epub 2010 Feb 5.

Abstract

PU.1 is a key transcription factor for hematopoiesis and plays important roles in various hematological malignancies. To clarify the molecular function of PU.1, we initially tried to identify bona fide target genes regulated by PU.1. Dual microarrays were employed for this study to compare PU.1-knockdown K562 cells (K562PU.1KD) stably expressing PU.1 short inhibitory RNAs versus control cells and PU.1-overexpressing K562 cells (K562PU.1OE) versus control cells. In these analyses, we found that several genes, including metallothionein (MT)-1 isoforms (MT-1G and MT-1A) and vimentin (VIM), were markedly induced while Jun dimerization protein (JDP) 2 was suppressed in K562PU.1KD cells. Furthermore, the mRNA expressions of the MT-1 and VIM genes were inversely correlated and the mRNA expression of JDP2 was positively correlated with PU.1 mRNA expression in 43 primary acute myeloid leukemia specimens (MT-1G: R = -0.50, p < 0.001; MT-1A: R = -0.58, p < 0.0005; VIM: R = -0.39, p < 0.01; and JDP2: R = 0.30, p < 0.05). Next, we analyzed the regulation of the MT-1 and VIM genes. We observed increased associations of acetylated histones H3 and H4 with the promoters of these genes in K562PU.1KD cells. Sequence analyses of the regions approximately 1 kb upstream from the transcription start sites of these genes revealed numerous CpG sites, which are potential targets for DNA methylation. Chromatin immunoprecipitation assays revealed that methyl CpG-binding protein 2 (MeCP2) and PU.1 bound to the CpG-rich regions in the MT-1 and VIM promoters. Bisulfite sequencing analyses of the PU.1-bound regions of these promoters revealed that the proportions of methylated CpG sites were tightly related to the PU.1 expression levels.

摘要

PU.1 是造血的关键转录因子,在各种血液恶性肿瘤中发挥重要作用。为了阐明 PU.1 的分子功能,我们最初试图鉴定受 PU.1 调控的真正靶基因。这项研究采用双微阵列比较稳定表达 PU.1 短发夹 RNA 的 K562PU.1KD 细胞与对照细胞以及过表达 PU.1 的 K562 细胞(K562PU.1OE)与对照细胞之间的差异。在这些分析中,我们发现几种基因,包括金属硫蛋白(MT)-1 同工型(MT-1G 和 MT-1A)和波形蛋白(VIM),在 K562PU.1KD 细胞中明显上调,而 Jun 二聚化蛋白(JDP)2 则受到抑制。此外,在 43 例急性髓系白血病标本中,MT-1 和 VIM 基因的 mRNA 表达呈负相关,JDP2 的 mRNA 表达与 PU.1 的 mRNA 表达呈正相关(MT-1G:R=-0.50,p<0.001;MT-1A:R=-0.58,p<0.0005;VIM:R=-0.39,p<0.01;JDP2:R=0.30,p<0.05)。接下来,我们分析了 MT-1 和 VIM 基因的调控情况。我们观察到 K562PU.1KD 细胞中这些基因启动子上乙酰化组蛋白 H3 和 H4 的结合增加。这些基因转录起始位点上游约 1kb 区域的序列分析显示存在许多 CpG 位点,这些位点可能是 DNA 甲基化的靶标。染色质免疫沉淀实验显示,甲基化 CpG 结合蛋白 2(MeCP2)和 PU.1 结合到 MT-1 和 VIM 启动子的富含 CpG 区域。这些启动子上 PU.1 结合区域的亚硫酸氢盐测序分析显示,CpG 位点的甲基化比例与 PU.1 的表达水平密切相关。

相似文献

1
Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.
J Biol Chem. 2010 Apr 2;285(14):10300-9. doi: 10.1074/jbc.M109.095810. Epub 2010 Feb 5.
2
Epigenetic regulation of the metallothionein-1A promoter by PU.1 during differentiation of THP-1 cells.
Biochem Biophys Res Commun. 2013 Apr 12;433(3):349-53. doi: 10.1016/j.bbrc.2013.03.007. Epub 2013 Mar 15.
3
Correlation of PU.1 and signal regulatory protein α1 expression in PU.1 transgenic K562 cells.
Int J Mol Med. 2012 Feb;29(2):319-23. doi: 10.3892/ijmm.2011.827. Epub 2011 Nov 7.
4
Identification of annexin 1 as a PU.1 target gene in leukemia cells.
Leuk Res. 2009 Dec;33(12):1658-63. doi: 10.1016/j.leukres.2009.04.010. Epub 2009 May 9.
6
The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells.
Biochem Biophys Res Commun. 2012 Apr 20;420(4):775-81. doi: 10.1016/j.bbrc.2012.03.071. Epub 2012 Mar 20.
7
Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia.
Int J Hematol. 2012 Jul;96(1):65-73. doi: 10.1007/s12185-012-1106-x. Epub 2012 Jun 7.
8
[Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):169-75. doi: 10.3760/cma.j.issn.0253-3766.2012.03.003.
10
Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
J Biol Chem. 2014 May 23;289(21):14881-95. doi: 10.1074/jbc.M114.562447. Epub 2014 Apr 2.

引用本文的文献

2
MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X.
Cancer Biol Ther. 2022 Dec 31;23(1):234-242. doi: 10.1080/15384047.2022.2054243.
3
Antioxidant Defenses in the Human Eye: A Focus on Metallothioneins.
Antioxidants (Basel). 2021 Jan 11;10(1):89. doi: 10.3390/antiox10010089.
4
A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing.
Nat Commun. 2019 Aug 14;10(1):3660. doi: 10.1038/s41467-019-11591-1.
5
The roles of metallothioneins in carcinogenesis.
J Hematol Oncol. 2018 Aug 23;11(1):107. doi: 10.1186/s13045-018-0645-x.
6
Multiple DNA-binding modes for the ETS family transcription factor PU.1.
J Biol Chem. 2017 Sep 29;292(39):16044-16054. doi: 10.1074/jbc.M117.798207. Epub 2017 Aug 8.
7
The Functions of Metallothionein and ZIP and ZnT Transporters: An Overview and Perspective.
Int J Mol Sci. 2016 Mar 4;17(3):336. doi: 10.3390/ijms17030336.
8
A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation.
PLoS One. 2014 Jul 29;9(7):e103282. doi: 10.1371/journal.pone.0103282. eCollection 2014.
9
The differentiation effect of low-dose cytosine arabinoside is disturbed in PU.1-knockdown K562 cells.
Biomed Rep. 2014 Jul;2(4):564-568. doi: 10.3892/br.2014.265. Epub 2014 Mar 31.
10
Molecular functions of metallothionein and its role in hematological malignancies.
J Hematol Oncol. 2012 Jul 27;5:41. doi: 10.1186/1756-8722-5-41.

本文引用的文献

1
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation.
Biochem Biophys Res Commun. 2009 Dec 4;390(1):48-53. doi: 10.1016/j.bbrc.2009.09.059. Epub 2009 Sep 19.
2
Identification of annexin 1 as a PU.1 target gene in leukemia cells.
Leuk Res. 2009 Dec;33(12):1658-63. doi: 10.1016/j.leukres.2009.04.010. Epub 2009 May 9.
3
CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.
Int J Lab Hematol. 2009 Jun;31(3):344-51. doi: 10.1111/j.1751-553X.2008.01056.x. Epub 2008 Mar 25.
4
Highly methylated genes in colorectal neoplasia: implications for screening.
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2686-96. doi: 10.1158/1055-9965.EPI-07-0518.
5
The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Genes Cells. 2007 Aug;12(8):905-18. doi: 10.1111/j.1365-2443.2007.01104.x.
6
Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
Nat Genet. 2006 Nov;38(11):1269-77. doi: 10.1038/ng1898. Epub 2006 Oct 15.
7
Prognostic significance of metallothionein in B-cell lymphomas.
Blood. 2006 Nov 15;108(10):3514-9. doi: 10.1182/blood-2006-04-015305. Epub 2006 Jul 25.
8
Prognostic significance of PU.1 in follicular lymphoma.
J Pathol. 2006 Jul;209(3):352-9. doi: 10.1002/path.1986.
9
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.
Oncogene. 2006 Apr 20;25(17):2477-88. doi: 10.1038/sj.onc.1209272.
10
Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.
Leuk Res. 2006 Jun;30(6):659-64. doi: 10.1016/j.leukres.2005.07.015. Epub 2005 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验